DAVID KEEN: Open Payments
NPI 1295759512 · CRAWFORDVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 24 payments from 9 companies in 2025. Trend: 2023 $801 · 2024 $1,039 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| UCB, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Exact Sciences Corporation | 2 | $41 |
| Radius Health, Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Verona Pharma, Inc. | 1 | $19 |
Products named: AIRSUPRA, FARXIGA, Kerendia, Bimzelx, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Tymlos, CAPLYTA.
Industry payments across FL — which companies pay providers there.
